Bloomage BioTechnology Corporation Limited (SHA:688363)

Market Cap	20.57B -14.3%
Revenue (ttm)	4.22B -21.5%
Net Income	291.07M +67.0%
EPS	0.61 +69.4%
Shares Out	478.36M
PE Ratio	70.49
Forward PE	36.76
Dividend	0.11 (0.25%)
Ex-Dividend Date	Jul 14, 2025

Volume	2,965,468
Average Volume	2,971,143
Open	43.95
Previous Close	43.96
Day's Range	43.00 - 44.37
52-Week Range	42.51 - 61.85
Beta	0.69
RSI	34.11
Earnings Date	Apr 23, 2026

About SHA:688363

Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under th...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2000
• Employees: 3,860
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688363

Financial Performance

In 2025, SHA:688363's revenue was 4.22 billion, a decrease of -21.49% compared to the previous year's 5.37 billion. Earnings were 291.07 million, an increase of 67.03%.